BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021

May 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-05-06

Reporting Person: MEIER RICHARD A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-06	Common Stock	M	15000	$26.49	Acquired	99340	Direct
2021-05-06	Common Stock	S	5068	$78.383	Disposed	94272	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-06	Stock Option (Right to buy Common Stock)	$26.49	M	15000	Disposed	2021-05-11	Common Stock (15000)	Direct

Footnotes

F1: The price in column 4 is the weighted average price. The price actually received ranged from $78.38 to $78.405. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.